Literature DB >> 23700324

MicroRNA biomarkers in glioblastoma.

Simon Kjær Hermansen1, Bjarne Winther Kristensen.   

Abstract

Recent research suggests that deregulation of microRNAs (miRNAs) is involved in initiation and progression of many cancers, including gliomas and that miRNAs hold great potential as future diagnostic and therapeutic tools in cancer. MiRNAs are a class of short non-coding RNA sequences (18-24 nucleotides), which base-pair to target messenger RNA (mRNA) and thereby cause translational repression or mRNA degradation based on the level of complementarity between strands. Profiling miRNAs in clinical glioblastoma samples has shown aberrant expression of numerous miRNAs when compared to normal brain tissues. Understanding these alterations is key to developing new biomarkers and intelligent treatment strategies. This review presents an overview of current knowledge about miRNA alterations in glioblastoma while focusing on the clinical future of miRNAs as biomarkers and discussing the strengths and weaknesses of various methods used in evaluating their expression.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23700324     DOI： 10.1007/s11060-013-1155-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  77 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

2.  Detection of microRNAs and assays to monitor microRNA activities in vivo and in vitro.

Authors:  Marianthi Kiriakidou; Peter Nelson; Stella Lamprinaki; Anup Sharma; Zissimos Mourelatos
Journal:  Methods Mol Biol       Date:  2005

3.  Blood alterations preceding clinical manifestation of glioblastoma.

Authors:  Aysegül Ilhan-Mutlu; Ludwig Wagner; Adelheid Wöhrer; Susanne Jungwirth; Christine Marosi; Peter Fischer; Matthias Preusser
Journal:  Cancer Invest       Date:  2012-10-12       Impact factor: 2.176

Review 4.  Alterations of microRNAs contribute to colon carcinogenesis.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

5.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

6.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

7.  MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.

Authors:  Simon Kjær Hermansen; Rikke Hedegaard Dahlrot; Boye Schnack Nielsen; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2012-10-28       Impact factor: 4.130

Review 8.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

9.  Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM).

Authors:  W J Lukiw; J G Cui; Y Y Li; F Culicchia
Journal:  J Neurooncol       Date:  2008-08-31       Impact factor: 4.130

10.  Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma.

Authors:  Johannes H Schulte; Tobias Marschall; Marcel Martin; Philipp Rosenstiel; Pieter Mestdagh; Stefanie Schlierf; Theresa Thor; Jo Vandesompele; Angelika Eggert; Stefan Schreiber; Sven Rahmann; Alexander Schramm
Journal:  Nucleic Acids Res       Date:  2010-05-13       Impact factor: 16.971
View more
  30 in total

Review 1.  Molecular heterogeneity of glioblastoma and its clinical relevance.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2014-08-27       Impact factor: 3.201

2.  Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.

Authors:  Qing Ouyang; Gang Chen; Ji Zhou; Lei Li; Zhen Dong; Rui Yang; Lunshan Xu; Hongjuan Cui; Minhui Xu; Liang Yi
Journal:  Neuro Oncol       Date:  2015-07-14       Impact factor: 12.300

3.  Serum microRNA-128 as a biomarker for diagnosis of glioma.

Authors:  Jun Sun; Keman Liao; Xuechao Wu; Jin Huang; Shuai Zhang; Xiaojie Lu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 4.  MicroRNA as potential biomarkers in Glioblastoma.

Authors:  Zammam Areeb; Stanley S Stylli; Rachel Koldej; David S Ritchie; Tali Siegal; Andrew P Morokoff; Andrew H Kaye; Rodney B Luwor
Journal:  J Neurooncol       Date:  2015-09-21       Impact factor: 4.130

5.  LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression.

Authors:  Xinzhi Liu; Yimamu Yidayitula; Heng Zhao; Yi Luo; Xiaoqiang Ma; Minhua Xu
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-18       Impact factor: 4.223

Review 6.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

7.  miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.

Authors:  Furong Wei; Qianrong Wang; Qinghong Su; Haiyan Huang; Junwen Luan; Xiaoqun Xu; Junfu Wang
Journal:  Cell Mol Neurobiol       Date:  2016-02-08       Impact factor: 5.046

Review 8.  Circulating biomarkers for gliomas.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

9.  Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.

Authors:  Eleonora Brognara; Enrica Fabbri; Elena Bazzoli; Giulia Montagner; Claudio Ghimenton; Albino Eccher; Cinzia Cantù; Alex Manicardi; Nicoletta Bianchi; Alessia Finotti; Giulia Breveglieri; Monica Borgatti; Roberto Corradini; Valentino Bezzerri; Giulio Cabrini; Roberto Gambari
Journal:  J Neurooncol       Date:  2014-03-05       Impact factor: 4.130

10.  miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study.

Authors:  Simon Kjær Hermansen; Boye Schnack Nielsen; Charlotte Aaberg-Jessen; Bjarne Winther Kristensen
Journal:  J Histochem Cytochem       Date:  2015-12-23       Impact factor: 2.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.